Cosmetic Surgery Market Size To Expand at a Notable CAGR Of 7.65% During 2024 to 2032

Increasing Focus on Aesthetics and Technological Advancements to Drive the Global Cosmetic Surgery Market at a CAGR of 7.65% During the Forecast Period 2025 to 2035

Market Research Future (MRFR) has published a cooked research report on the “Global Cosmetic Surgery Market” that contains information from 2025 to 2035. The Cosmetic Surgery Market is estimated to register a CAGR of 7.65% during the forecast period of 2025 to 2035.

MRFR recognizes the following companies as the key players in the Global Cosmetic Surgery Market — Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Ipsen (FR), Hugel (KR), Sientra (US), and Croma-Pharma (AT).

Market Highlights

The Global Cosmetic Surgery Market is accounted for to register a CAGR of 7.65% during the forecast period and is estimated to reach USD 135.51 Billion by 2035.

The market is growing mainly because social media is becoming more important, people are making more money, surgical techniques are getting better, and more people are willing to have cosmetic procedures. Combining AI, telemedicine, and 3D imaging technologies is changing the way doctors talk to patients, plan procedures, and care for them after surgery, making them safer and more satisfying.

People are increasingly choosing cosmetic procedures that don't require surgery or only require a small amount of surgery. This is because these procedures allow for faster recovery and less pain. Botox injections, dermal fillers, and laser therapies are becoming more and more popular, especially among younger people who want results that are subtle and tailored to them.

Companies are putting more money into AI-driven technologies, digital consultations, and more advanced product formulations to make treatments more accurate and help patients get better results. For example, in 2025, Allergan came out with a new line of advanced dermal fillers. Revance Therapeutics is also using AI-based platforms to make the patient experience better.

Also, the market is growing because more people are becoming aware of how cosmetic enhancements can improve mental health. The industry is also getting a boost from good rules and regulations, especially in the U.S. and Europe, that make sure both surgical and non-surgical procedures are safe and effective.

Segment Analysis

The Global Cosmetic Surgery Market has been segmented based on Procedure Type, End User, Invasive Procedure, Non-Invasive Procedures.

The Procedure Type segment is segmented into Invasive, Non-Invasive. The Invasive segment dominates the market. Cosmetic surgeries like liposuction, breast augmentation, and facelifts are the most popular. This group of procedures makes up a large part of all cosmetic procedures, showing that there is a steady demand from people who want to make big changes to their appearance.

The Invasive Procedure segment is segmented into Breast Augmentation, Liposuction, Nose Reshaping, Eyelid Surgery, Tummy Tuck, Others. The biggest part is breast augmentation. This procedure is popular with a lot of people because it makes them feel better about their bodies, gives them more confidence, and makes them feel more in control of their lives. Liposuction is not the most popular procedure, but it is quickly becoming one because it works well for shaping the body, and more people are learning about less invasive methods.

The Non-Invasive Procedure segment is segmented into Botox Injections, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, Microdermabrasion, Dermabrasion, Others. Botox injections have the biggest market share because they are well-known and widely accepted by consumers.

The End-User segment is segmented into Hospitals and Dermatology Clinics, Ambulatory Surgical Centers, Others. Hospitals and Dermatology Clinics. Their large infrastructure, skilled staff, and wide range of services make them a good choice for a lot of different cosmetic procedures, which appeals to a wide range of people.

Regional Analysis

By region, the Cosmetic Surgery Market is segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. North America accounted for approximately 40% of the global market share in 2024, making it the largest regional market. Growth is driven by high consumer awareness, advanced healthcare infrastructure, strong regulatory oversight, and the presence of leading companies such as Allergan and Revance Therapeutics. The U.S. leads the region with widespread adoption of both invasive and non-invasive procedures, supported by FDA approvals and high spending on aesthetic treatments.

Key Findings of the Study

• The Global Cosmetic Surgery Market is expected to reach USD 135.51 billion by 2035, growing at a CAGR of 7.65% during the forecast period.

• North America accounted for the largest share in 2024, followed by Europe and Asia-Pacific as the fastest-growing region.

• Based on Procedure Type, the Invasive Procedures segment dominated the market in 2024.

• Based on End User, Hospitals and Dermatology Clinics held the largest market share in 2024.

• Key players include Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Ipsen (FR), Hugel (KR), Sientra (US), and Croma-Pharma (AT).

Related Reports